NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes

Lise Tarnow30 enrolled

Overview

The aim of the study is to examine the suitability to detect diabetic neuropathy using NIR and impedance.

The aim of the study is to examine how suitable a hand-held measuring probe (DDD-probe) using NIR (near infrared light) as well as impedance (conductivity), is to detect early signs of diabetic neuropathy. The DDD-probe is put directly on the skin and is measuring by the use of light and impedance.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diabetic Neuropathy

Eligibility

Sex: MALEMin age: 35 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * men with type 1 diabetes (WHO criteria) * age 35-50 years * duration of diabetes \> 10 years Exclusion Criteria: * P-creatinine\> 120 micromol/l * other acute or chronic disease, or type of treatment that makes the patient unsuitable to participate, valuated by the investigator * non intact skin on the measuring spots * the patient is unable to understand the informed consent

Locations (1)

Steno Diabetes Center

Gentofte Municipality, Denmark

Outcomes

Primary Outcomes

near infrared spectroscopy

Near infrared (NIR) is measured by spectroscopy on the skin using the DDD probe

Time frame: one time

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.